(Q38074225)

28 August 2017

0 references

1 reference

title

A systematic review and meta-analysis of propionyl-L-carnitine effects on exercise performance in patients with claudication (English)

1 reference

28 August 2017

1 reference

3

William R Hiatt

1 reference

28 August 2017

Eric P Brass

1

1 reference

28 August 2017

David Koster

series ordinal

2

1 reference

28 August 2017

Antonino Amato

series ordinal

4

1 reference

28 August 2017

publication date

15 January 2013

1 reference

28 August 2017

1 reference

28 August 2017

volume

18

1 reference

28 August 2017

issue

1

1 reference

28 August 2017

page(s)

3-12

1 reference

Medical treatment of peripheral arterial disease and claudication

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1358863X12467491

Management of lower extremity peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X12467491

Peripheral arterial disease rehabilitation: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X12467491

Conservative management of intermittent claudication

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X12467491

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X12467491

Long-term safety of cilostazol in patients with peripheral artery disease: the CASTLE study (Cilostazol: A Study in Long-term Effects).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X12467491

Skeletal muscle metabolic changes in peripheral arterial disease contribute to exercise intolerance: a point-counterpoint discussion

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X12467491

The myopathy of peripheral arterial occlusive disease: Part 2. Oxidative stress, neuropathy, and shift in muscle fiber type.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X12467491

New insights concerning the role of carnitine in the regulation of fuel metabolism in skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X12467491

L-carnitine supplementation to diet: a new tool in treatment of nonalcoholic steatohepatitis--a randomized and controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X12467491

Effects of L-carnitine supplement on serum inflammatory cytokines, C-reactive protein, lipoprotein (a), and oxidative stress in hemodialysis patients with Lp (a) hyperlipoproteinemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X12467491

L-carnitine supplementation attenuates intermittent hypoxia-induced oxidative stress and delays muscle fatigue in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X12467491

European multicenter study on propionyl-L-carnitine in intermittent claudication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X12467491

Propionyl-L-carnitine improves exercise performance and functional status in patients with claudication

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X12467491

Effect of Propionyl-L-carnitine on a Background of Monitored Exercise in Patients With Claudication Secondary to Peripheral Artery Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X12467491

l-Carnitine. A preliminary review of its pharmacokinetics, and its therapeutic use in ischaemic cardiac disease and primary and secondary carnitine deficiencies in relationship to its role in fatty acid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X12467491

Treatment of intermittent claudication with physical training, smoking cessation, pentoxifylline, or nafronyl: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X12467491

A pooled analysis of the durability and predictors of treatment response of cilostazol in patients with intermittent claudication

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X12467491

Exercise for intermittent claudication

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X12467491

Effect of cilostazol on treadmill walking, community-based walking ability, and health-related quality of life in patients with intermittent claudication due to peripheral arterial disease: meta-analysis of six randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X12467491

Pharmacokinetics of L-carnitine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X12467491

Superiority of L-propionylcarnitine vs L-carnitine in improving walking capacity in patients with peripheral vascular disease: an acute, intravenous, double-blind, cross-over study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X12467491

A threshold exists for the stimulatory effect of insulin on plasma L-carnitine clearance in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X12467491

21 January 2018

Propionyl-L-carnitine

1 reference

https://api.crossref.org/works/10.1177%2F1358863X12467491

21 January 2018

Identifiers

DOI

10.1177/1358863X12467491

1 reference

28 August 2017

1 reference